ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Forest plot of randomized trials of fish oils in at-risk populations and in patients with cardiovascular disease assessing the outcome of cardiovascular death

Forest plot of randomized trials of fish oils in at-risk populations and in patients with cardiovascular disease assessing the outcome of cardiovascular death
Random effects model meta-analysis of omega-3 FA versus placebo (or no omega-3 FA), with subgroup analyses by population. In all meta-analyses, only studies that reported sufficient data are included.
CVD: cardiovascular disease; FA: fatty acids; n/N: number with outcome/number analyzed; CI: confidence interval; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; PHET: p-value of the test for statistical heterogeneity.
References:
  1. Roncaglioni MC, Tombesi M, Avanzini F, et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013; 368:1800.
  2. Einvik G, Klemsdal TO, Sandvik L, et al. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2010; 17:588.
  3. Bosch J, Gerstein HC, Dagenais GR, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367:309.
  4. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1897.
  5. Nilsen DW, Albrektsen G, Landmark K, et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001; 74:50.
  6. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008; 372:1223.
  7. Kromhout D, Giltay EJ, Geleijnse JM, et al. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363:2015.
Reproduced from: Balk EM, Adam GP, Langberg V, et al. Omega-3 fatty acids and cardiovascular disease: An updated systematic review. Evidence Report/Technology Assessment No. 223. (Prepared by the Brown Evidence-based Practice Center under Contract No. 290-2012-00012-I.) AHRQ Publication No. 16-E002-EF. Rockville, MD: Agency for Healthcare Research and Quality; August 2016. https://effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research/.
Graphic 59845 Version 5.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟